Rapid virological response in peripheral blood mononuclear cells with an increase of hepatitis C virus-specific interferon-gamma production predisposes to sustained virological response in patients with chronic hepatitis C genotype 1 undergoing treatment with pegylated-interferon alpha 2a plus ribavirin
- 8 December 2009
- journal article
- research article
- Published by Taylor & Francis in Scandinavian Journal of Gastroenterology
- Vol. 45 (2) , 250-255
Abstract
Objective. Viral load evaluation in plasma, after 1 month of treatment, represents one of the most important parameters to predict treatment response during interferon (IFN) treatment in chronic hepatitis C (CHC). It has been proven that hepatitis C virus (HCV) RNA may be present in peripheral blood mononuclear cells (PBMCs) but few studies have investigated the viral load in PBMCs during treatment. The aim of this study was to evaluate HCV RNA in PBMCs during therapy with pegylated-IFN-α2a plus ribavirin and whether its clearance in PBMCs may induce a treatment response. Furthermore, we also analyzed the IFN-γ and interleukin (IL)-4 responses of PBMCs during therapy. Material and methods. We studied 35 patients with CHC genotype 1 undergoing antiviral treatment with pegylated IFN-α2a 180 μg weekly plus ribavirin 1000 mg/daily. In these patients we evaluated HCV-RNA in plasma and PBMCs, IFN-γ and IL-4 before treatment, after 1, 3 and 12 months of treatment and 6 months after the end of treatment. Results. We found that rapid virological clearance of HCV-RNA in PBMCs with a restored and improved HCV-specific IFN-γ response was statistically significantly higher in those with a sustained virological response (SVR). Conclusion. Patients having a rapid virological response in PBMCs with an improved Th1 network achieve a complete SVR, whereas those having viral clearance only in plasma without a restored Th1 network have a relapse.Keywords
This publication has 10 references indexed in Scilit:
- Polyfunctional HCV‐specific T‐cell responses are associated with effective control of HCV replicationEuropean Journal of Immunology, 2008
- Influence of extrahepatic viral infection on the natural history of hepatitis CAnnals of Hepatology, 2008
- Real-Time PCR Assays for Hepatitis C Virus (HCV) RNA Quantitation Are Adequate for Clinical Management of Patients with Chronic HCV InfectionJournal of Clinical Microbiology, 2006
- Detection of Hepatitis C Virus (HCV) RNA in the Liver of Healthy, Anti?HCV Antibody–Positive, Serum HCV RNA–Negative Patients with Normal Alanine Aminotransferase LevelsThe Journal of Infectious Diseases, 2006
- Interleukin-10 and tumor necrosis factor-alpha: model of immunomodulation in multiple sclerosisNeurological Research, 2006
- Predicting sustained virological responses in chronic hepatitis C patients treated with peginterferon alfa-2a (40KD)/ribavirinJournal of Hepatology, 2005
- Immunology of hepatitis B virus and hepatitis C virus infectionNature Reviews Immunology, 2005
- Persistence of hepatitis C virus in patients successfully treated for chronic hepatitis CHepatology, 2004
- Hepatitis C virus non‐structural protein 4 suppresses Th1 responses by stimulating IL‐10 production from monocytesEuropean Journal of Immunology, 2003
- Projecting future complications of chronic hepatitis C in the United StatesLiver Transplantation, 2003